Draft:Zenon Sosnowski

• Comment: Most of the content is unreferenced. Please ensure that every material statement is backed up by citation of a reliable source. -- DoubleGrazing (talk) 11:57, 3 April 2022 (UTC)

• Comment: I don't think he passes the notability criteria for entry on Wikipedia: I do not see how he passes WP:GNG or WP:PROF. He was not a tenured professor, just a researcher/lecturer. I found very little about him on the internet, which can be an indicator of a subject's notability—- I did find an obituary and have added it as a reference. Please see if you can find more independent, reliable, third-party sources ((WP:IRS) Cabrils (talk) 21:49, 9 January 2022 (UTC)

---

Zenon Sosnowski
Born	(1931-01-01)January 1, 1931 Krasne, Rzeszów County, Poland
Died	December 21, 2014(2014-12-21) (aged 83)
Nationality	Polish
Occupation(s)	Medical researcher and lecturer
Known for	Medical research on propolis
Notable work	Therapeutic value of flavonoids in Rhinovirus infections A comparative multi-centre study of the efficacy of propolis, acyclovir and placebo in the treatment of genital herpes (HSV) The effects of Herstat (3% propolis ointment ACF) application in cold sores: A double-blind placebo-controlled clinical trial
Children	2

Zenon Michael Sosnowski, MSc, PhD (January 1, 1931 – December 21, 2014) was a Polish medical researcher and lecturer . As a double PhD in biochemistry and microbiology, his most notable work involved researching and developing propolis-based natural health products. Through various research programmes he developed methods to extract antiviral and antimicrobial properties from propolis produced by honeybees to create an active ingredient that could be used in various medicinal treatments including the development of viricidal treatments to combat the herpes virus.

Early life

Sosnowski was born in Krasne, Poland, to Rozalia and Bazyli Sosnowski on New Year's Day, 1931. During the Second World War, he sold newspapers and cigarettes to soldiers to help support his family. After the war, Sosnowski sailed the world with the German Merchant Marine.

Sosnowski started working at an American field hospital in Nuremberg during the 1950s, where he would develop an interest in the medical sciences.

Academic work

In 1964, Sosnowski immigrated to Winnipeg, Canada to work at the Children's Hospital and General Hospital of Winnipeg. In the 1970s, he took up a position as a lecturer at the University of Manitoba, where he taught students at St. Boniface Hospital's Satellite Lab.

He completed two PhDs in biochemistry and microbiology.

Research on Propolis

During his research, Sosnowski became interested in the medicinal potential of propolis, a resinous substance that honeybees produce by mixing beeswax and saliva with exudate collected from plant sources. After his work as a lecturer, Sosnowski eventually went on to found his own independent research company, Api-Remedica Industries, which was set up with the goal of pursuing research into how Canadian propolis could be used in health foods, nutraceuticals, and cosmetics to fight harmful bacteria and viruses.

In 1987, Sosnowski was part of a trial that tested propolis's efficacy against common cold infections, which involved 50 patients at the Marcinkowski's Medical Academy in Poznan. The findings showed that the symptoms of patients treated with propolis lasted 2.5 times shorter than patients treated with placebo.

Sosnowski carried out years of important, early research into the effects of formulations containing purified Manitoban bee propolis in MRSA infected wounds. But perhaps most crucially he perfected complex techniques using an ethanolic, cold filtration and extraction process to maximise and enhance the net concentration of phenolic content (particularly flavonoids, flavones, stilbenes, lignans and proanthocyanins) in purified propolis, extracted from crude material harvested from beehives.

Sosnowski's medical research surrounding propolis culminated in the production of Propolis ACF®, a purified propolis extract used as the active ingredient in skincare products. The extract yielded very favourable results in clinical trials testing its efficacy against the Herpes Simplex Virus (both type 1, which causes cold sores, and type 2, which causes genital herpes), in a groundbreaking trial co-authored by globally recognised propolis expert Vassya Bankova.. For both types of the virus, Propolis ACF was shown to heal lesions and reduce symptoms significantly faster than placebo.

Because of its efficacy against HSV, Propolis ACF® has been used as the active ingredient in cold sore treatments, including the ointments ColdsoreFX, Propovir, and Herstat.

His many publications on the efficacy of propolis extracts are often cited in modern studies, the impact of Dr. Zenon Sosnowski's work on propolis is far-reaching, influencing both scientific understanding and potential medical applications. His early research continues to open new possibilities for the integration of propolis-derived compounds into mainstream healthcare practices.

Personal life and death

Sosnowski married his wife, Genowefa, in 1967. He fathered two sons.

He died on December 21, 2014, after a long battle with cardiovascular disease. He is survived by his wife and two sons. He continued his research up until the time of his death.

References

This page will be placed in the following categories if it is moved to the article namespace.

Categories:

• 1931 births
• 2014 deaths